Category: Press Releases

New solution will allow businesses to aggregate and calculate life cycle assessments quickly and at scale

CHICAGO, May 11, 2022 (GLOBE NEWSWIRE) — Sphera®, a leading global provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services, today announced the launch of its new Life Cycle Assessment (LCA) Automation software, building upon the company’s existing LCA solutions. The move comes as investor and regulatory pressures surrounding the standardization and digitalization of end-to-end sustainability data measurement continue to mount, necessitating increasingly sophisticated and granular reporting and compliance tools.

Sphera’s next-generation solution integrates seamlessly with customers’ existing systems for rapid deployment, allowing customers to quickly receive holistic, real-time analysis and insights into the environmental footprint of their product portfolios. It also features extensive managed content that enables customers to instantaneously calculate their carbon footprint at scale and model how adjustments to specific variables—such as leveraging a cleaner power source or altering production processes—may affect emissions outputs.

The LCA Automation solution serves as an extension of Sphera’s existing Product Sustainability capabilities which include life cycle assessment software and content. The service allows a company to increase the number of LCAs by a factor of 1,000, in turn enabling the experienced LCA professional to focus on analyzing and improving results, versus creating them.

The overarching goal of Sphera’s LCA Automation tool is to help businesses—especially those in sectors with complex supply chains, such as manufacturing, consumer goods, paints and chemicals—to more effectively reduce their greenhouse gas (GHG) emissions at every step of production, from design to disassembly. Improved forecasting will facilitate holistic corporate decisions with sustainability incorporated at each stage, allowing teams to proactively predict and control environmental impact.

Paul Marushka, Sphera’s CEO and president, says: “Historically, LCAs have been viewed as voluntary, ad-hoc add-ons to broader corporate sustainability efforts. However, with consumer awareness growing in-step with regulatory mandates to mitigate the effects of climate change, LCA Automation feeds into the highest needs of decarbonization. As recent moves from the EU, SEC and the latest IPCC report have shown, financial and reputational fallout from a failure to act are very much a ‘when’, not an ‘if’.”

Continues Marushka, “From helping engineers create more sustainable products to enabling procurement professionals to establish lower carbon emission supply chains, LCA Automation will transform decision-making, for the benefit of both businesses and our planet.”

About Sphera
Sphera is the leading provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services focusing on Environment, Health, Safety & Sustainability (EHS&S), Operational Risk Management and Product Stewardship. For more than 30 years, we have served over 3,000 customers and a million-plus users in 80 countries to help companies keep their people safe, their products sustainable and their operations productive. Learn more about Sphera at www.sphera.com. Follow Sphera on LinkedIn.

Contact Information:
Astrid Dickinson
sphera@aspectusgroup.com

ENZYCHEM LIFESCIENCES’ CHAIRMAN & CEO RECEIVES “TOP 100 INNOVATION CEO OF 2022 AWARD”.

LONDON, May 11, 2022 (GLOBE NEWSWIRE) — Ki Young Sohn is Chairman and CEO of Enzychem Lifesciences, a late-stage biotechnology company. With more than 30 years of experience in the life sciences and finance industry, Ki Young has previously led teams in various pharmaceutical settings to success. Most recently, he has led positive Phase 2 US results for Enzychem Lifesciences’ lead candidate, EC-18 in Chemoradiation-induced Oral Mucositis (CRIOM) and execution of the partnership with Zydus Cadila to manufacture and distribute the world’s first COVID-19 pDNA vaccine.

Founded in 1999, Enzychem Lifesciences is developing novel small molecule therapeutics to target fundamental pathways in inflammation, for patients with unmet needs. Based on more than two decades of research, Enzychem developed its leading candidate EC-18, an oral small molecule derived from Sika deer antler, which has shown to be active across a number of different indications.

In recognition of Ki Young Sohn’s invaluable contributions to the biopharmaceutical industry, and Enzychem Lifesciences’ focus on improving the lives of patients with cancer and inflammatory diseases, World Biz Magazine has awarded Mr. Sohn a position within the Top 30 of the global list of 100 distinguished honorees.

Ki Young Sohn was also interviewed in World Biz Magazine where he shared insights into Enzychem Lifesciences’ mission and factors driving the company’s rapid growth. Read the interview here.

“It is a great honor to receive World Biz Magazine’s ‘Top 100 Innovation CEO’ Award. Developing novel therapeutics to patients with unmet needs is at the heart of Enzychem’s mission and culture. We will continue to innovate and advance the development of our therapies for the patients,” said Ki Young Sohn, Chairman and CEO of Enzychem Lifesciences.

World Biz Magazine’s Top 100 Innovation CEO Awards celebrates business leaders across the globe that are making major strides in  their industries. It recognizes product, service, functional, strategic, and managerial innovation. It also recognizes individuals showing exceptional commercial insight and market integrity. Sustainability forms a key cornerstone of the awards and is an integral part of the selection criteria. Every year over 40,000 leaders are shortlisted and following a stringent evaluation process, only 100 winners are selected.

Mike Walters, Editor in Chief of World Biz Magazine: “We are pleased to announce Ki Young Sohn as a recipient of the Award. To be highlighted within the Top 30 of the 100 winners is a testament to the pivotal role of Enzychem Lifesciences under Ki Young Sohn’s leadership in focusing on patients with significant unmet needs in oncology, inflammatory, and severe respiratory diseases.  Aside from its innovation DNA and exciting growth, Enzychem Lifesciences is an ESG centric company, best exemplified by its commitment to making COVID-19 vaccination available in low-medium income countries across Latin America and Asia.”

World Biz Magazine is the leading global C-Suite business journal with a readership spanning 32 countries, WBM focuses on leadership, innovation, investment and social responsibility. worldbizmagazine.net

Enzychem Lifesciences (KOSDAQ: 183490) is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for patients with unmet medical needs in oncology, metabolic and inflammatory diseases. EC-18 acts as an immunomodulator, facilitating the resolution of inflammation and early return to homeostasis. Enzychem is headquartered in South Korea, with an office in the United States. enzychem.com

Press contact: John West, awards@worldbizmagazine.com

Related Images

Image 1: KI YOUNG SOHN, CEO OF ENZYCHEM

This content was issued through the press release distribution service at Newswire.com.

Attachment

• KI YOUNG SOHN, CEO OF ENZYCHEM

New facility will also serve as regional headquarters for Singleron in Asia

SINGAPORE, May 10, 2022 (GLOBE NEWSWIRE) — Proteona Pte. Ltd., a subsidiary of Singleron Biotechnologies, and a leader in single-cell multi-omics analysis, today announced the opening of a new operations facility in Science Park 2, Singapore.

The new state-of-the-art laboratory is capable of processing over 1,200 samples annually using Singleron and third-party single-cell technologies. It significantly increases Proteona’s capacity to support customers that desire an outsourced solution for single-cell multi-omic sample processing and machine-learning-based data analysis. “Beyond increasing our capacity, the new space allows us to provide new services based on Singleron’s innovative single-cell technologies, expanding the menu of single-cell analysis methods that our customers can access,” said Dr. Jonathan Scolnick, CSO of Proteona and General Manager of Singleron Singapore.

The new site will function as the regional headquarters for Singleron in Asia outside China with a focus on servicing customers in Singapore, the surrounding Asia-Pacific region, and in the global pharmaceutical and biotechnology industry. The opening of the new facility will also create new bioscience job opportunities in Singapore for both laboratory and commercial personnel. “Placing the laboratory in Singapore was not a coincidence, but a strategic choice,” said Dr. Nan Fang, CEO of Singleron. “Singapore’s strong biomedical ecosystem, coupled with its skilled labor force and location in Asia made it an ideal choice for our new Asian regional headquarters.”

Proteona was launched in 2018 by co-founders Dr. Jonathan Scolnick, Dr. Gene Yeo, and Dr. Shawn Hoon and as spin-out of the National University of Singapore and A*STAR. It was acquired by Singleron Biotechnologies, based in Nanjing and Suzhou, China and Cologne, Germany in March of 2022.

About Proteona
Proteona is a biomedical company that is pioneering the use of single-cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single-cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample-to-answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.

Media Contact
Name: Shaun Cordes
Email: pr@singleron.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/acef2c19-661f-4299-a63f-be9a17f8841b

Improves Access to Critical Rodent Models for Researchers in India

RENSSELAER, N.Y., May 10, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has appointed Nomura Siam International Co., Ltd (NSI), an established distributor of laboratory animals and related products, as its preferred distributor in India.

India makes a significant contribution to global pharmaceutical and vaccine production, and its pharmaceutical and biotechnology research and development is expected to grow over the next decade. To support this growth, scientists in India need advanced mouse and rat models for pharmacology studies and toxicology and drug safety assessment. Research across all therapeutic areas requires genetically engineered models (GEMs). Additionally, mice with humanized immune systems are critical for immuno-oncology and other applications.

Taconic’s portfolio comprises nearly 4,700 mouse and rat models, including widely used standard strains, immunodeficient models, and exclusive GEMs. Taconic is also a global leader in humanized immune system mouse generation. Taconic’s industry-leading quality systems, genetic integrity, and globally harmonized animal health standards promote research reproducibility while its flexible approach to licensing reduces barriers to accessing valuable GEMs.

Based in Thailand, NSI is known for its focus on quality and customer service. The company’s new agreement with Taconic significantly increases preclinical researchers’ access to GEMs in India and allows NSI to offer this market a full spectrum of solutions.

“To date, rodent model selection and availability has been somewhat limited in India. We believe this partnership will provide India’s growing pharmaceutical industry access to the most sophisticated and high-quality animal models available globally,” said Dr. Michael Seiler, vice president of commercial products at Taconic. “We truly believe this partnership will support Taconic’s desire to accelerate new life-saving therapeutics for the global community.”

“Taconic’s portfolio of sophisticated mouse models fills a major gap in the Indian market,” said Taiichiro Kamiya, president of NSI. “By our frequent information sharing, and the improvement of logistic process, we will provide faster and easier access to GEMs for Indian users.”

To learn more about Taconic’s full line of animal model solutions, please call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the US and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

About Nomura Siam International Co. Ltd. (NSI)

Nomura Siam International Co. Ltd., based in Bangkok, Thailand, was jointly established in 2012 by CLEA Japan, Inc. and Nomura Jimusho, Inc. as a comprehensive provider for the laboratory animal field. As a one-stop service supplier, NSI not only sells laboratory animals but also handles a wide range of related products, including equipment for breeding, conducting experiments, and environmental enrichment, as well as consulting services for preclinical research and laboratory animal facility design.

Media Contact:

Aidan Bouchelle
Associate Director, Marketing Operations
518-949-7598
Aidan.Bouchelle@taconic.com

FRANKFURT AM MAIN, Germany, May 10, 2022 (GLOBE NEWSWIRE) — DQS Group is online with its new website: The relaunch of the homepage is in line with the new, globally uniform brand strategy: under the claim “Simply leveraging Quality” DQS positions itself as an international thought leader that offers its customers meaningful added value and a seamless customer experience through audits and certifications of processes and management systems.

“In an increasingly complex and dynamic world, people and organizations find it increasingly difficult to obtain stability and a sense of purpose. As a certification body, we can help to create trust, security, and orientation,” explains Ingo M. Rübenach, Managing Director of DQS Holding GmbH. “In order to meet this responsibility, we decided to analyze our brand presence and adapt it to the requirements of a digital business world. The result is our new brand strategy, uniform across around 60 countries, which is reflected in the website for the first time, but will shape our actions for years to come.”

The DQS brand: Ambitious, competent, dynamic

In today’s agile and uncertain world, people and organizations are increasingly losing their clarity and orientation: highly professional, often state-sponsored actors are causing confusion online with targeted disinformation campaigns and deceptively genuine deep fakes. Even beyond digitization, more and more criminals are taking advantage of the increasing complexity to enrich themselves with fake products, fake news, or sophisticated social engineering.

Trust is the most valuable currency

In online and offline business, trust thus becomes a valuable currency, and a proven way to earn the trust of customers and partners is to have one’s processes audited and certified by reliable third parties. For this purpose, DQS positions itself as a competent and learned partner that understands its customers’ processes, contributes to their success with practicable impetus, and generates tangible added value on many levels with audits and certifications:

•  Certificates provide a robust foundation for organizations to gain credibility and build trusting customer relationships – and, conversely, help customers and consumers to quickly and reliably evaluate suppliers, products, and services in a dynamic world.
• Certificates are a prerequisite for successful market access in an increasing number of industries and segments, for example in the automotive industry or for manufacturers of medical devices.
• Certifications are a valuable sign of quality and differentiation in the market. A proof of environmental management in accordance with ISO 14001 is a weighty argument for many customers in times of climate change, and rightly so.
• Being open to new ideas, DQS enables organizations to improve their processes for the benefit of their customers and to set the course for simple, smooth certification and a high quality customer experience with innovative solutions.

A website for your knowledge advantage in more than 30 languages 

“From now on, we present ourselves on our homepage as a sustainable and modern brand that is known for quality in service as well as for innovation and intelligent approaches to digital solutions,” explains DQS manager Rübenach. “And also with a view to the rapidly advancing globalization of our business, the relaunch represents an important step forward for us: from now on, we will offer visitors all over the world the same broad range of information and the same high usability worldwide. This reinforces our claim to be a reliable partner for customers around the globe when it comes to continuously improving management systems and processes.”

Readers can find more information at www.dqsglobal.com.

Press contact:
Dr. Dieter Stadler
Corporate Marketing
DQS Holding GmbH
August-Schanz-Straße 21
60433 Frankfurt am Main
Tel.: +49 69 95427-313
E-Mail: info@dqsglobal.com
www.dqsglobal.com

Related Images

Image 1: Ingo M. Rübenach

“From now on, we present ourselves on our homepage as a sustainable and modern brand that is known for quality in service as well as for innovation and intelligent approaches to digital solutions,” explains DQS Manager Rübenach.

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Ingo M. Rübenach

Adding Short-Takeoff & Landing Capability to Industry-Leading RPA Enhances Versatility

SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) — To further extend the versatility of its MQ-9B line of Remotely Piloted Aircraft, General Atomics Aeronautical Systems, Inc. (GA-ASI) announced today that it will begin developing a short takeoff and landing (STOL)-capable MQ-9B aircraft, which includes the SkyGuardian^® and SeaGuardian^® models. GA-ASI is taking on this revolutionary engineering effort to meet an evolving operational environment in contested expeditionary environments.

GA-ASI began STOL development in 2017 as part of its Mojave initiative. STOL capability was initially flown on a modified Gray Eagle Extended Range platform in 2021, but now the company will begin developing STOL on the MQ-9B, a platform already selected by the Royal Air Force, the Belgium Ministry of Defence, and the Japan Coast Guard. MQ-9B STOL will combine GA-ASI’s proven long-endurance, highly reliable UAS products with the versatility to execute missions in more austere locations, opening the operational envelope for commanders across all services and geographic locations.

The MQ-9B STOL configuration will consist of an optional wing and tail kit that can be installed in less than a day. The core aircraft and its sub-systems remain the same. Operators can perform the modification in a hangar or on a flight line, delivering a capability that otherwise would require the purchase of a whole new aircraft.

“Imagine taking the hardtop off your Jeep. You lift it off, stow it in your garage, and now you’ve got an open vehicle. If it rains, you put the hardtop back on. We’re the same. Take a standard MQ-9B, put the STOL kit on, and then go fly,” said GA-ASI President David R. Alexander.

MQ-9B STOL, which is part of GA-ASI’s Mojave series of unmanned aircraft, also presents an opportunity for future operations aboard an aircraft carrier or big-deck amphibious assault ship. The wings fold so that MQ-9B STOL could be parked on the deck or in the hangar bay, just like other naval aircraft. When it’s time to launch, operators will start the aircraft, unfold the wings, and take off over the bow without the need for catapults. GA-ASI believes the U.S. Navy and Marine Corps will take note of this innovation as it opens the door to persistent and long-range Intelligence, Surveillance and Reconnaissance (ISR) operations over blue water.  

About GA-ASI

General Atomics-Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable remotely piloted aircraft (RPA) systems, radars, and electro-optic and related mission systems, including the Predator^® RPA series and the Lynx^® Multi-mode Radar. With more than seven million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent flight that enables situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.

Avenger, Lynx, Predator, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc. 

CONTACT:
GA-ASI Media Relations
General Atomics Aeronautical Systems, Inc.
+1 (858) 524-8101
ASI-MediaRelations@ga-asi.com

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Featured Image for General Atomics Aeronautical Systems, Inc.

Software designed by Industrial Hygiene experts uses industry best practices, rapid time-to-valueCority Software Logo

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — It’s estimated that over 2 million people globally lose their lives each year due to diseases linked to workplace exposure to harmful substances. While many organizations have industrial hygiene programs in place, shrinking hygiene budgets and the loss of hygiene experts are making the effort to effectively manage these exposures, and thereby reduce the risk of occupational illness, much more challenging. In response to the market need, leading global EHS (Environment, Health, and Safety) software provider, Cority, announced today the availability of its Hygiene Essentials solution, providing businesses an entry point to digitizing their industrial hygiene management program simply, affordably, and quickly.

Cority’s Hygiene Essentials packages industry best practices and proven workflows in a ready-to-use, rapid time-to-value solution that can scale with a customer’s growth and changing needs. The solution enables organizations to manage all quantitative and qualitative occupational exposure assessment data in one central place, in real-time, to clearly identify hazards, evaluate and manage risks, and develop an effective and comprehensive hygiene program to protect their workforce in the near and long term.

Industrial hygiene hazards are largely invisible and difficult to predict; their effects may not manifest for decades. Without reliable data that quantifies the risk – including the degree of exposure, the exposure duration, and the number of people exposed – organizations may not feel a sense of urgency to prioritize these sorts of potential issues over more seemingly immediate health and safety risks.

“Companies invest in solving problems they can see and measure. Lung disease from long-term chemical exposure or hearing loss related to high noise levels are much less tangible and immediate than a broken leg from a slip and fall accident,” said Sean Baldry, senior product marketing manager for Cority. “Cority provides organizations with the tools to act now and make informed decisions about where and how to invest in the health of their employees before the exposure becomes a bigger problem and their reputation as a responsible employer is negatively impacted.”

The Hygiene Essentials solution gives companies the ability to:

• Automate monitoring plans to speed up performance tracking, transfer data to external labs, and compare results against exposure limits to determine compliance
• Record and upload monitoring data from the field on any mobile device, reducing secondary administration and errors, helping to address issues early
• Group employees based on user-defined criteria to streamline monitoring plans and extrapolate results to trigger associated surveillance activities
• Track metrics and uncover key insights to help make data-driven decisions to manage hygiene risk

“Leveraging our internal team’s backgrounds in industrial hygiene and safety, as well as our experience configuring custom solutions for our customers, we build the wealth of that knowledge into the software,” said Laura Beeler, senior manager of EHS solutions for Cority who has previously served in a number of health and safety roles within global enterprises. “You don’t have to have an industrial hygienist on staff or know advanced statistics to be able to use the solution.”

The Cority teams’ level of demonstrated industrial and occupational hygiene expertise was a key factor in Dow Chemical Company’s selection of Cority to replace its outdated homegrown solution that was used for decades to manage employee risks.

“Some other solutions offered industrial hygiene packages, but they weren’t primarily focused on industrial hygiene,” said Jim Weldy, industrial hygiene manager for Dow. “The details matter. If a vendor doesn’t really understand how you’re trying to protect workers, the solution can miss the boat rather significantly.”

Hygiene Essentials is also part of CorityOne^TM, the company’s integrated EHS SaaS-based platform, which provides a scalable and seamless path for future growth. The responsible business platform enables datasets to be combined from across the organization for realizing improved efficiencies, actionable insights, data-driven decisions, and more accurate reporting. Building on an organization’s industrial hygiene program, clients can easily unify all their EHS programs into a single comprehensive platform to uncover key insights and create a single, accurate, and holistic view of EHS performance.

Hygiene Essentials is the second Essentials solution released by Cority this year and the fifth in its product portfolio. Like all Cority’s Essentials packages, the solution is designed for rapid deployment, providing a starting point based on best practices and proven processes and focusing on foundational elements of an occupational hygiene program. The Essentials packages drive accelerated adoption and quick wins that organizations can build on for future expansion by offering faster time-to-value and lower total cost of ownership. Hygiene Essentials is a standardized version of Cority’s comprehensive Industrial Hygiene solution under the Cority Health Cloud.

Media Contact: Meredith Schweitzer +1-347-698-9196 mschweitzer@66and.co

###

About Cority

Cority is the leading global enterprise Environmental, Health, and Safety (EHS) software provider creating industry-leading technology to empower those who transform the way the world works. For over 35 years, Cority has been powered by the spirit of innovation, deep domain expertise, and a commitment to integrity that enables higher levels of operational and sustainable performance with the most comprehensive, human-centered, and secure SaaS platform to help workers and businesses thrive in 100 countries around the world. The company enjoys the industry’s highest levels of client satisfaction and has received many awards for its strong employee culture and outstanding business performance. To learn more, visit www.cority.com.

Related Images

Image 1: Cority Software Logo

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Cority Software Logo